Centene Corp. stock pre-market at EUR 56.34: plus 0.64 percent
Centene Corp. stock traded pre-market at EUR 56.34, marking a 0.64 percent increase from its previous closing price of EUR 55.98 at Lang & Schwarz on October 2, 2026. The pre-market quote was recorded at 8:51 a.m. CEST on October 5, 2026, ahead of the Xetra open. Investors are observing the stock's performance in anticipation of the official Xetra trading session.
Centene stock gained 3.28 percent as earnings recovery took hold
Centene stock rose by 3.28% to USD 62.99 on October 2, 2026, following a strong Q2 2026 earnings report where adjusted EPS reached USD 2.51 and revenue hit USD 53.6 billion. Management also raised full-year 2026 guidance, with total revenue expected between USD 193.5 billion and USD 197.5 billion and adjusted EPS above USD 4.80. Analysts maintain a "Buy" rating with an average 12-month price target of USD 71.78, indicating potential for further upside despite a decrease in total membership.
Centene Corp stock gains 3.28 percent as earnings outlook improves
Centene Corp (CNC) saw its stock rise by 3.28% on October 2, 2026, closing at USD 62.99, following a strong Q2 earnings report. The company's adjusted diluted EPS significantly beat analyst expectations at USD 2.51, leading to an upward revision of its full-year 2026 adjusted EPS guidance to above USD 4.80. Despite some membership pressure, analysts like Cantor Fitzgerald maintain a Buy rating with a target price of USD 75.00, suggesting further upside potential.
UnitedHealth Reports on Oct. 13. Here's the 1 Number I'm Watching.
UnitedHealth Group is scheduled to report its third-quarter financial results on October 13. While investors will scrutinize revenue and earnings per share, the author emphasizes the importance of the medical care ratio, which indicates the percentage of premiums paid out for claims. This metric is crucial for assessing the insurer's profitability and will reveal if UnitedHealth maintained its efforts to lower it.
Centene Corp (CNC) Stock Up 3.3% and Still Undervalued -- GF Sco
Centene Corp (CNC) shares rose 3.3% to $62.99, marking a strong year-to-date performance with a 53.1% increase, and are considered "Modestly Undervalued" by GuruFocus' GF Value, which estimates its intrinsic value at $78.48. Despite this, the company's unprofitability, negative cash flow, and insider selling signal caution for potential investors, as reflected in its GF Score of 71/100, which highlights strong valuation but weak growth.
UnitedHealth and Humana cutting Medicare Advantage plans in 2027
UnitedHealth and Humana are discontinuing Medicare Advantage plans covering over one million seniors, with CVS Health's Aetna and Centene also scaling back. This move is a response to rising medical costs and insufficient government reimbursement, leading to insurers pulling back from less profitable markets for the 2027 enrollment year. Affected members will need to select new plans, and UnitedHealth will restructure its offerings to focus on lower-cost options.
F5 Networks, Inc. (FFIV) latest stock news and headlines
This article provides a compilation of recent news and headlines regarding F5 Networks, Inc. (FFIV), including its stock performance and analyst coverage. It highlights F5's recognition as a leader in WAAP Platforms and its developments in AI security, while also noting its strong year-to-date stock performance.
Centene Corporation (CNC) Options Chain - Yahoo Finance
This page from Yahoo Finance provides options chain data for Centene Corporation (CNC). As of the closing time, the stock was trading at $62.99, up 3.28% for the day. However, the options chain shows no calls or puts available, and the data is delayed by 15 minutes.
Centene Corp. provides 2026 earnings guidance: 21 analysts rate Centene Corp. stock Hold
Centene Corp. has released its 2026 earnings per share guidance at USD 4.80, which is below the analyst consensus of USD 4.89, despite the company's second-quarter revenue of USD 53.58 billion exceeding estimates by a significant margin. Twenty-one analysts currently maintain a "Hold" rating on Centene Corp. stock. The company's stock was trading at EUR 54.68, with its NYSE quote remaining below its yearly high.
Lincoln Financial Closes $6.3 Billion Reinsurance Transaction with Talcott
Lincoln Financial (NYSE: LNC) has finalized a $6.3 billion reinsurance transaction with Talcott Financial Group, effective October 1, 2026. This deal involves the reinsurance of approximately $5.8 billion of in-force guaranteed universal life (GUL) statutory reserves, covering about 37% of Lincoln's remaining GUL block. Combined with a previous transaction in 2023, this brings the total reinsured GUL business to approximately 60%, significantly reducing Lincoln's exposure to this legacy, capital-intensive business.
Centene (CNC): Pricing Actions and Profit Stabilization Drive Earnings Recovery
Cambiar Opportunity Fund highlighted Centene Corporation (NYSE: CNC) as a top performer in Q2 2026, crediting pricing actions and underwriting for stabilizing profits in the healthcare sector. Despite its recovery and significant year-to-date gain, the fund notes that current earnings are still 30-50% below normalized levels. Truist also maintained a Buy rating and increased its price target for Centene.
Zacks.com featured highlights include Banco Macro, Centene, Enersys, Gibraltar Industries and Kennametal
This article from Zacks.com highlights five low price-to-book (P/B) stocks with attractive value and strong growth potential: Banco Macro (BMA), Centene Corp. (CNC), Enersys (ENS), Gibraltar Industries (ROCK), and Kennametal (KMT). It explains the P/B ratio as a valuation metric, details how book value is calculated, and discusses the interpretation and limitations of using the P/B ratio for investment decisions. Each featured company is briefly described, along with its Zacks Rank, Value Score, and projected EPS growth rate.
Form 4 Centene Corp For: 1 October By Investing.com
The article reports on a Form 4 filing for Centene Corp (CNC) for activity on October 1st. It provides a brief mention of the filing and includes the stock's current performance (-0.14%). The rest of the content consists of general market data, news headlines, and promotional material from Investing.com.
Zacks.com featured highlights include Banco Macro, Centene, Enersys, Gibraltar Industries and Kennametal
This article from Zacks.com highlights five low price-to-book (P/B) stocks with attractive value and strong growth potential: Banco Macro S.A. (BMA), Centene Corp. (CNC), Enersys (ENS), Gibraltar Industries (ROCK), and Kennametal (KMT). It explains the concept of the P/B ratio as a valuation metric, detailing how it's calculated and interpreted to identify potentially undervalued companies, while also acknowledging its limitations and the need to consider other financial ratios.
Centene reaffirms 2026 guidance: Centene stock sits 10.79 percent below its high
Centene Corporation reaffirmed its full-year 2026 earnings guidance, projecting GAAP diluted earnings per share above $3.11 and adjusted diluted earnings per share above $4.80. This guidance follows a strong second quarter, with the stock currently trading 10.79 percent below its 52-week high of $69.63. Analysts maintain a consensus Hold rating with an average 12-month price target of $70.05.
Centene Corp Director Christopher J. Coughlin Reports Acquisition of 583 Shares
Centene Corporation Director Christopher J. Coughlin acquired 583 shares of Centene Corp common stock at no cost, as disclosed in a Form 4 filed with the SEC on September 30, 2026. This transaction increases his direct beneficial ownership to 19,293.926 shares, which includes restricted stock units, and he also indirectly holds 30,054 shares through a grantor retained annuity trust.
After a 603-share grant, Centene (CNC) director Kenneth Tanji holds 13,093 shares.
Centene Corp. director Kenneth Tanji received a grant of 603 shares of common stock on September 30, 2026. Following this transaction, his direct holdings increased to 13,093 shares, which includes 3,992 previously granted restricted stock units that are subject to vesting requirements. The report details the transaction and the new total ownership, emphasizing the nature of these holdings.
A director received 864 shares at Centene (CNC) on September 30, 2026.
Centene Corp. director Frederick H. Eppinger was granted 864 shares of common stock on September 30, 2026, increasing his direct position to 370,402 shares, which includes previously granted restricted stock units. This transaction is categorized as a neutral filing in terms of impact and sentiment.
A 583-share award at $0 goes to Centene (CNC) director Theodore R. Samuels II.
Centene Corp. director Theodore R. Samuels II received an award of 583 shares of common stock at $0.00 per share on September 30, 2026. Following this transaction, his direct holdings totaled 25,796 shares, which include restricted stock units, and an additional 32,000 shares were held indirectly through a revocable family trust. This transaction was reported in a Form 4 SEC filing.
Comfort Systems USA (NYSE:FIX) Share Price Crosses Above Two Hundred Day Moving Average - Should You Sell?
Comfort Systems USA (NYSE:FIX) briefly traded above its 200-day moving average of $1,708.46, reaching $1,712.60 before settling at $1,663.68. The company reported strong Q2 earnings with EPS of $12.53 and 50.3% year-over-year revenue growth, and increased its quarterly dividend to $0.90. Despite a consensus "Buy" rating from analysts with an average target of $2,082.86, insiders have sold over $43 million in stock in the last 90 days.
CareSource, Molina to drop ACA Marketplace plans in Ohio in 2027
CareSource and Molina Healthcare of Ohio will exit the Affordable Care Act (ACA) Marketplace in Ohio in 2027, impacting approximately 54,000 current enrollees. CareSource cited rising healthcare costs and shifts in the ACA Marketplace as reasons for its decision, while Molina Healthcare Inc. reported declining profits and higher medical care ratios in its recent earnings. Ohioans affected by this change will need to select new plans during the open enrollment period for 2027, with nine other companies approved to sell individual plans on the exchange.
8% of hospital-insurer contract disputes go public: study
A new study in Health Affairs reveals that about 8% of hospital-insurer contract relationships escalated into public disputes between 2021 and 2025, but only 2% of these actually resulted in a contract dissolution. For-profit hospitals are twice as likely to engage in "brinkmanship," publicly threatening to leave an insurer's network to secure better rates, especially when they hold significant but not overwhelming local market power. This tactic is driven by hospitals seeking higher rates to cover rising costs and offset low federal reimbursement, with researchers noting a tension between affordability for consumers and the dramatic negotiation strategies employed by providers.
Centene stock: Company reaffirms 2026 EPS guidance
Centene Corporation reaffirmed its full-year 2026 GAAP diluted EPS guidance of greater than $3.11 and adjusted diluted EPS guidance of greater than $4.80. This reaffirmation was made during the Deutsche Bank 2026 Healthcare Summit and subsequent investor discussions. The guidance was effective through September 25, 2026, as noted in a September 16 SEC Form 8-K filing.
Centene Corporation (CNC) Latest Stock News & Headlines
This article compiles recent news and headlines concerning Centene Corporation (CNC), including stock performance updates and various analyst reports. The news covers topics such as growth stock recommendations, the company's credentialing initiatives, and community investments. The overview also includes Centene's trailing total returns compared to the S&P 500 benchmark.
Centene Corporation (CNC) Stock Price, News, Quote & History
This Yahoo Finance page provides a comprehensive overview of Centene Corporation (CNC), including its current stock price, recent news, and historical performance. As of September 29, 2026, CNC's stock closed at $62.21, with various news articles discussing its growth prospects, financial health, and comparisons to peers. The performance overview highlights significant year-to-date and 1-year gains, outperforming the S&P 500.
Centene Corporation (CNC) Interactive Stock Chart
This Yahoo Finance page provides an interactive stock chart for Centene Corporation (CNC), displaying its current stock price, daily change, and after-hours trading. It also lists recent news articles related to Centene, including updates on growth stocks, credentialing programs, and market performance.
Centene stock gains 1.08 percent as EPS guidance holds
Centene stock increased by 1.08% after the company reaffirmed its full-year 2026 GAAP diluted EPS guidance above USD 3.11 and adjusted diluted EPS guidance above USD 4.80. Analysts have a consensus "Hold" rating with an average 12-month price target of USD 70.05, suggesting potential upside from the current price. The company's Q2 revenue was USD 53.58 billion, up 9.9% year over year, with EPS of USD 2.51.
Centene Corporation stock last trades at USD 62.38 on September 28, 2026
Centene Corporation stock last traded at USD 62.38 on September 28, 2026, marking a 0.91% increase. The company had previously reaffirmed its 2026 earnings guidance in September, projecting GAAP diluted EPS greater than USD 3.11 and adjusted diluted EPS greater than USD 4.80. This guidance was effective through September 25, 2026, and the company stated it would not update it unless publicly announced.
Centene Corporation (CNC) options chain
This article from Yahoo Finance provides the options chain for Centene Corporation (CNC), detailing its stock performance and available options data. It lists the current stock price, recent trading activity, and indicates that there are no calls or puts currently available for the specified strike prices. The article also includes related tickers in the healthcare sector.
Centene Corp Lobbying Profile, 2023
This page provides a lobbying profile for Centene Corp for the year 2023, detailing their federal lobbying expenditures. As of July 23, 2026, Centene Corp spent $2.49 million directly on lobbying activities in the first half of 2026. The data is compiled by OpenSecrets, a nonpartisan organization tracking money in U.S. politics.
Form 4 Centene Corp For: 26 September By Investing.com
This article announces the filing of Form 4 for Centene Corp (CNC) for September 26. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is a change in the beneficial ownership of a company's securities by its directors, officers, or any shareholder owning more than 10% of the company's stock. The article provides only this brief notification and includes various market data and related news from Investing.com.
Form 4 Centene Corp For: 26 September By Investing.com
This article announces the filing of a Form 4 for Centene Corp on September 26. It appears to be a very brief notification from Investing.com, accompanied by various market data and other news headlines.
Form 4 Centene Corp For: 26 September By Investing.com
This article announces the filing of a Form 4 for Centene Corp on September 26. A Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is a material change in the holdings of company insiders.
Form 4 Centene Corp For: 26 September By Investing.com
The article reports on a Form 4 filing for Centene Corp (CNC) dated September 26, 2026. Form 4 is a document filed with the SEC by company insiders to report changes in their ownership of the company's securities. The brief article provides no further details on the specific transactions.
Form 4 Centene Corp For: 25 September By Investing.com
This article from Investing.com reports on a Form 4 filing for Centene Corp on September 25, 2026. Form 4s disclose changes in ownership of company stock by insiders. The article provides the date of the filing and mentions Centene Corp's stock symbol CNC, along with its current price change.
Form 4 Centene Corp For: 25 September By Investing.com
This article reports on the filing of Form 4 for Centene Corp on September 25. It is a brief announcement from Investing.com, indicating an insider transaction or change in beneficial ownership for the company, Centene Corp (CNC), with its stock price noted as -0.16%. The main content of the article is the announcement itself, without further details on the Form 4.
Form 4 Centene Corp For: 25 September
This article announces the filing of a Form 4 for Centene Corp on September 25th. Form 4 filings are legally required documents submitted to the SEC by company insiders detailing their transactions in company stock. The article itself is very brief, mainly serving as a notification.
Form 4 Centene Corp For: 25 September By Investing.com
This article announces the filing of a Form 4 for Centene Corp on September 25. It is a very brief news item, primarily consisting of the title repeated several times. The content is essentially a placeholder for an insider trading report.
New analysis points finger at payers for IDR problems
A new analysis from specialty medical societies contends that payers are largely responsible for problems with the No Surprises Act's independent dispute resolution (IDR) process. The report suggests that payers frequently lose disputes due to non-participation or procedural failures, and often submit unreasonably low offers, contradicting their complaints about high provider win rates. The groups shared their findings with Congress, urging enforcement of payer obligations and allowing recent IDR process changes to take effect before implementing blanket reforms.
Centene Corporation (CNC) stock price, news, quote and history
This article provides a comprehensive overview of Centene Corporation (CNC), a managed care company, including its current stock price, recent performance, and financial data. It details the company's operational segments such as Medicaid, Medicare, and Commercial, and offers analyst insights, earnings trends, and valuation measures. The report highlights CNC's YTD return of 50.23% and a 1-year return of 79.76%.
Centene Corp. stock stays above USD 60 after earnings beat
Centene Corp. (ISIN US15133V1035) saw its stock trade above USD 60 after reporting strong Q2 2026 earnings, including total revenue of USD 53.579 billion and adjusted EPS of USD 2.51, surpassing expectations. The company also raised its 2026 guidance for total revenue and adjusted EPS. Analysts maintain an average target price of USD 70.05, indicating a potential upside of over 13% from its September 24, 2026, closing price of USD 61.91.
CVS Health’s Aetna Guide Tops Out at $5.37 Billion. Here’s Why It Matters.
CVS Health's Aetna division is projected to reach an adjusted operating income of $5.37 billion in 2026, which merely returns it to 2021 levels after a significant drop in 2024. The article highlights a concern that AI tools used by providers are identifying more billable diagnoses without a corresponding increase in treatment, potentially driving up healthcare costs. This trend, already noted by other insurers, could impact Aetna's medical cost trends and leaves CVS with a thin cushion given its 2027 EPS consensus is only slightly above management's stated floor.
Centene Corp. stock heads into the open after closing at USD 62.08
Centene Corp. stock closed at USD 62.08 on September 24, 2026, after the S&P 500 experienced a slight decline. The stock traded 3.26 million shares, with its closing level being 10.8% below its 52-week high. Centene shares enter the next session after a recent market commentary noted a 79.2% 12-month gain.
Five Texas Hospitals Tied to HCA Sue Independence Blue Cross Over $345,000 in Denied Claims, Including Emergency Care
Five HCA-affiliated hospitals in Texas have sued Independence Blue Cross, a Philadelphia-based insurer, over $345,000 in allegedly denied or underpaid claims for eight members, including emergency care. The lawsuit claims the insurer violated federal and state law by requiring prior authorization for emergency services and failing to provide specific clinical reasons for denials. This dispute highlights ongoing issues within the BlueCard Program regarding varying authorization rules and medical necessity standards across different Blue Cross Blue Shield plans.
eHealth, Inc. (EHTH) Latest Stock News & Headlines - Yahoo Finance
This page provides a collection of the latest news and headlines concerning eHealth, Inc. (EHTH), including collaborations with BerniePortal and a top Medicare carrier, reports on rising employer health costs, and survey results related to Medicare understanding. The stock's recent performance is also highlighted, showing significant negative returns year-to-date and over the past one and three years.
Centene Corp. stock heads into the open after a 0.84 percent drop
Centene Corp. stock experienced a 0.84% drop, closing at USD 66.64 on September 23, 2026, amidst a broader market decline where the Nasdaq Composite fell 1.10%. Despite a 98.75% gain over the past year, the stock saw a 6.4% loss in the previous week, indicating short-term volatility. Trading volume for the day was 2,184,000 shares, with the stock fluctuating between USD 66.20 and USD 67.31.
Zacks.com featured highlights include Centene, BrightSpring Health Services and Delek US
This article highlights three momentum anomaly stocks — Centene Corp. (CNC), BrightSpring Health Services, Inc. (BTSG), and Delek US Holdings, Inc. (DK) — that Zacks recommends buying as markets surge due to an AI rally. It explains momentum investing as a strategy to profit from continuing stock trends, especially when value or growth investing underperforms. The selected companies, despite recent short-term pullbacks, have shown significant price gains over the past year and boast a Momentum Score of A.
UnitedHealth, Cigna, Centene join forces on provider credentialing
UnitedHealth, Cigna, and Centene are collaborating with CertifyOS to streamline provider credentialing, aiming to reduce the process from months to days. This partnership is expected to significantly improve efficiency in getting healthcare providers approved for insurance networks. The initiative highlights a joint effort by major healthcare companies to address administrative bottlenecks in the industry.
Cerenome Secures In-Network Agreement With Blue Cross Blue Shield of Michigan, Expanding CNSide Contracted Coverage to Approximately 158 Million Covered Lives
Cerenome has announced an in-network agreement with Blue Cross Blue Shield of Michigan, significantly expanding the contracted coverage for its CNSide test. This deal adds over 5.4 million lives to CNSide's network, bringing the total to approximately 158 million covered lives and marking a major step in improving access to specialized diagnostic testing for neurological conditions.
Centene Corp. stock underperforms Tuesday when compared to competitors
Centene Corp. stock (CNC) fell 2.60% on Tuesday, closing at $63.30, while the broader market showed mixed results with the S&P 500 largely unchanged and the Dow Jones Industrial Average experiencing a slight decline. This marked the third consecutive day of losses for Centene Corp.
